Abstract
Carboplatin-etoposide chemotherapy for patients with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC); outcomes from a European Neuroendocrine Tumour Society Centre of Excellence
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have